All of the news, delivered with full-text to your inbox. For professionals discovering, developing, and marketing biopharmaceutical drugs.
SIGN UP NOWNovo Nordisk filed suit against another semaglutide compounder on Friday, bringing its total number of cases to 50.
READ MOREValneva is eyeing a 2027 launch for its Pfizer-partnered Lyme disease vaccine, CEO Thomas Lingelbach said Thursday during the company’s investor day.
READ MORENovartis used one of its priority review vouchers (PRV) to speed the September approval of Kisqali in early breast cancer, the FDA said Monday.
READ MORENovo Holdings is set to buy one less facility from Catalent as the manufacturer has sold a facility in New Jersey to a European CDMO. The sale also means Catalent is looking for a new ...
READ MORE